Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
65
65 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- KVA12123Phase 21 trial
Kineta Inc. · Cancer, Solid Tumor, Melanoma
- lonigutamabPhase 21 trial
ACELYRIN Inc. · Thyroid Eye Disease
- MAR002Phase 21 trial
Marea Therapeutics · Acromegaly
- NBIP-01435Phase 21 trial
Neurocrine Biosciences · Congenital Adrenal Hyperplasia
- NEO-201Phase 21 trial
Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer
- NLS-133Phase 21 trial
Next Life Sciences · Male Contraception, Semen Volume, Sperm Motility
- NOE-115Phase 21 trial
Noema Pharma AG · Menopause Syndrome, Menopause, Hot Flashes
- NTB003Phase 21 trial
Nanjing Chia-tai Tianqing Pharmaceutical · Thyroid Eye Disease
- OG-6219Phase 21 trial
Organon and Co · Endometriosis
- SAL056Phase 21 trial
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Postmenopausal Women With Osteoporosis
- SNS-101anti-VISTAPhase 21 trial
Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer
- VipoglanstatPhase 21 trial
Gesynta Pharma AB · Endometriosis
- VLS-1488Phase 21 trial
Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer
- XP-102Phase 21 trial
Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma
- YCT-529Phase 21 trial
YourChoice Therapeutics, Inc. · Male Contraception
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.